🔴 Pacific Biosciences is trading 5% down today amid rising yields and biotech-sector losses

Pacific Biosciences is trading at $1.40, down 5.10%, as broad risk-off pressure weighs on growth-oriented biotech stocks.

• Rising crude oil and Treasury yields pressured market valuations and rate-sensitive sectors.
• The biotechnology sector is down 2.04%, while major U.S. indexes are also lower.
• No new company-specific announcement clearly explains the September 23 decline; the move follows September 22’s 8.09% gain.